|  IDAHO                                              |  82-0266517                    |
|---------------------------------------------------------------|-------------------------------------|
| (State or other jurisdiction ofincorporation or organization) | (I.R.S. EmployerIdentification No.) |

----

|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PART I. CONSOLIDATED FINANCIAL INFORMATION                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |  3 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |   |
| Item 1.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Financial Statements. |  3 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |      Condensed Consolidated Balance Sheets |  3 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |      Condensed Consolidated Statements of Operations  |  4 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |      Condensed Consolidated Statements of Cash Flows |  5 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |      Notes to Condensed Consolidated Financial Statements |  6 |
| Item 2.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Management's Discussion and Analysis of Financial Condition and Plan of Operations | 15 |
| Item 3.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Quantitative and Qualitative Disclosures About Market Risk | 19 |
| Item 4.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Controls and Procedures | 19 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |   |   |
| PART II. OTHER INFORMATION                                                                                                                                            | 21 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |   |
| Item 1.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Legal Proceedings | 21 |
| Item 1A.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Risk Factors | 21 |
| Item 2.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Unregistered Sales of Equity Securities and Use of Proceeds | 21 |
| Item 3.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | DefaultsUpon Senior Securities | 21 |
| Item 4.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Mine Safety Disclosure | 21 |
| Item 5.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Other Information | 21 |
| Item 6.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Exhibits |  21 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |   |  21 |
| Signatures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 22 |

----

| PART I. | CONSOLIDATED FINANCIAL INFORMATION |
|---------|------------------------------------|

| Item 1.   | Financial Statements. |
|---------------------|-----------------------|

| ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY                                                                |
|----------------------------------------------------------------------------------------------------------------|
| CONDENSED CONSOLIDATED  BALANCE SHEETS                                                               |
|                                                                                                           |   |   |   |   |
|                                                                                                           |   |   |   |   |
|                                                                                                           |   | June 30, |   | December 31, |
|                                                                                                           |   | 2012 |   | 2011 |
|                                                                                                           |   | (Unaudited) |   |   |
|                                                                                                           |   |   |   |   |
| ASSETS                                                                                                         |   |   |   |   |
|                                                                                                           |   |   |   |   |
| CURRENT ASSETS:                                                                                                |   |   |   |   |
|       Cash and cash equivalents                                                  |   | $          224,190 |   |  $         147,198 |
|       Accounts receivable, net                                                   |   |            113,521 |   |            375,463 |
|       Inventory, net                                                             |   |            306,890 |   |            327,314 |
|                                                                                                           |   |   |   |   |
|         Total current assets                                           |   |            644,601 |   |            849,975 |
|                                                                                                           |   |   |   |   |
|  FIXED ASSETS, NET                                                                                        |   | 124,357 |   | 135,681 |
|                                                                                                           |   |   |   |   |
|  OTHER ASSETS                                                                                             |   | 13,695 |   | 13,695 |
|                                                                                                           |   |   |   |   |
|     Total assets                                                                           |   |  $         782,653 |   |  $         999,351 |
|                                                                                                           |   |   |   |   |
|                                                                                                           |   |   |   |   |
|  LIABILITIES AND SHAREHOLDERS' (DEFICIENCY) EQUITY                                                   |   |   |   |   |
|                                                                                                           |   |   |   |   |
|  CURRENT LIABILITIES:                                                                                     |   |   |   |   |
|        Accounts payable and accrued expenses                                |   |  $         782,156 |   |  $         721,246 |
|        Customer deposits                                                    |   |              32,000 |   |                       - |
|        Current portion of note payable                                      |   | 14,522 |   | 32,107 |
|                                                                                                           |   |   |   |   |
|         Total current liabilities                                      |   |            828,678 |   |            753,353 |
|                                                                                                           |   |   |   |   |
|         Total liabilities                                              |   |            828,678 |   |            753,353 |
|                                                                                                           |   |   |   |   |
|  COMMITMENTS AND CONTINGENCIES (See Note G)                                                               |   |   |   |   |
|                                                                                                           |   |   |   |   |
|  SHAREHOLDERS' (DEFICIENCY) EQUITY:                                                                       |   |   |   |   |
|  Common stock, $.001 par value, 42,750,000 shares authorized;                                             |   |   |   |   |
|       33,214,497 and 32,864,497 shares issued and outstanding as of              |   |   |   |   |
|       June 30, 2012 and December 31, 2011                                        |   | 33,115 |   | 32,865 |
|  Additional paid-in capital                                                                               |   | 14,708,281 |   | 14,138,963 |
|  Deferred compensation                                                                                    |   | (47,500) |   | (266,000) |
|  Accumulated deficit                                                                                      |   | (14,739,921) |   | (13,659,830) |
|                                                                                                           |   |   |   |   |
|         Total shareholders' (deficiency) equity                        |   |             (46,025) |   |            245,998 |
|                                                                                                           |   |   |   |   |
|  Total liabilities and shareholders' (deficiency) equity                                                  |   |  $         782,653 |   |  $         999,351 |
|                                                                                                           |   |   |   |   |
| The accompanying notes are an integral part of the unaudited condensed consolidated financial statements  |

----

| ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY                                                                            |
|----------------------------------------------------------------------------------------------------------------------------|
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS                                                                            |
| (UNAUDITED)                                                                                                                |
|                                                                                                                       |   |   |   |   |   |   |   |
|                                                                                                                       |   |   |   |   |   |   |   |
|                                                                                                                       |   |   |   |   |
|                                                                                                                       |   Three Months Ended June 30, |   |   Six Months Ended June 30, |
|                                                                                                                       | 2012 |   | 2011 |   | 2012 |   | 2011 |
|                                                                                                                       |   |   |   |   |   |   |   |
|                                                                                                                       |   |   |   |   |   |   |   |
| Revenues, net                                                                                                              |  $           86,606 |   |  $       699,415 |   |  $          410,970 |   |  $     1,423,270 |
|                                                                                                                       |   |   |   |   |   |   |   |
| Cost of goods sold                                                                                                         |                 8,865 |   |             239,123 |   |             100,472 |   |             484,970 |
|                                                                                                                       |   |   |   |   |   |   |   |
| Gross profit                                                                                                               |               77,741 |   |             460,292 |   |             310,498 |   |             938,300 |
|                                                                                                                       |   |   |   |   |   |   |   |
| Costs and expenses:                                                                                                        |   |   |   |   |   |   |   |
|       General and administrative                                                             |             262,002 |   |             237,716 |   |             488,379 |   |             511,942 |
|       Consulting expense                                                                     |                       - |   |               97,948 |   |             788,068 |   |             195,896 |
|       Research and development                                                               |               56,213 |   |               81,924 |   |             109,646 |   |             197,433 |
|                                                                                                                       |   |   |   |   |   |   |   |
|                 Total costs and expenses   |             318,215 |   |             417,588 |   |           1,386,093 |   |             905,271 |
|                                                                                                                       |   |   |   |   |   |   |   |
| Income (Loss) from operations                                                                                              |            (240,474) |   |               42,704 |   |         (1,075,595) |   |               33,029 |
|                                                                                                                       |   |   |   |   |   |   |   |
| Other expenses:                                                                                                            |   |   |   |   |   |   |   |
|       Interest expense                                                                       |               (3,888) |   |               (1,912) |   |               (4,496) |   |               (3,372) |
|                                                                                                                       |   |   |   |   |   |   |   |
|               Total other expense                    |               (3,888) |   |               (1,912) |   |               (4,496) |   |               (3,372) |
|                                                                                                                       |   |   |   |   |   |   |   |
| Net Income (Loss)                                                                                                          |  $        (244,362) |   |  $       40,792 |   |        $  (1,080,091) |   |            $         29,657 |
|                                                                                                                       |   |   |   |   |   |   |   |
| Weighted average number of common shares                                                                                   |   |   |   |   |   |   |   |
|    outstanding-basic and diluted                                                                            | 33,214,497 |   | 27,201,762 |   | 33,197,464 |   | 27,201,762 |
|                                                                                                                       |   |   |   |   |   |   |   |
| Income (Loss) per common share - basic and diluted                                                                         |   $              (0.01) |   |   $           0.00 |   |  $           (0.03) |   |  $             0.00 |
|                                                                                                                       |   |   |   |   |   |   |   |
| The accompanying notes are an integral part of the unaudited condensed consolidated financial statements    |

----

| ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY                                                                            |
|----------------------------------------------------------------------------------------------------------------------------|
| CONDENSDED CONSOLIDATED STATEMENTS OF CASH FLOWS                                                                           |
| (UNAUDITED)                                                                                                                |
|                                                                                                                       |   |   |   |   |
|                                                                                                                       |   |   |   |   |
|                                                                                                                       |   | Six Months Ended June 30, |
|                                                                                                                       |   | 2012 |   | 2011 |
|                                                                                                                       |   |   |   |   |
| Cash Flows From Operating Activities:                                                                                      |   |   |   |   |
| Net loss                                                                                                                   |   |  $     (1,080,091) |   |  $          29,657 |
| Adjustments to reconcile net income (loss) to net                                                                          |   |   |   |   |
|   cash provided by (used in) operating activities:                                                                    |   |   |   |   |
|       Depreciation                                                                           |   |                11,324 |   |              11,309 |
|       Stock-based compensation                                                                    |   |              788,068 |   |            209,707 |
| Changes in assets and liabilities:                                                                                         |   |   |   |   |
|       Accounts receivable                                                                         |   |              261,942 |   |          (329,864) |
|       Inventory                                                                                   |   |                20,424 |   |          (261,665) |
|       Accounts payable and accrued expenses                                                       |   |                92,910 |   |              70,817 |
|                                                                                                                       |   |   |   |   |
|       Net cash provided by (used in) operating activities                                         |   |                94,577 |   |          (270,039) |
|                                                                                                                       |   |   |   |   |
| Cash Flows From Financing Activities:                                                                                      |   |   |   |   |
|       Repayments toward notes payable                                                             |   |              (17,585) |   |            (19,458) |
|                                                                                                                       |   |   |   |   |
|       Net cash used in financing activities                                                       |   |              (17,585) |   |            (19,458) |
|                                                                                                                       |   |   |   |   |
|         Net increase (decrease) in cash and cash equivalents                            |   |                76,992 |   |          (289,497) |
|                                                                                                                       |   |   |   |   |
|        Cash and cash equivalents, beginning of period                                        |   |              147,198 |   |            442,812 |
|                                                                                                                       |   |   |   |   |
|        Cash and cash equivalents, end of period                                              |   |  $          224,190 |   |  $        153,315 |
|                                                                                                                       |   |   |   |   |
| Supplemental Disclosures                                                                                                   |   |   |   |   |
|                                                                                                                       |   |   |   |   |
|       Cash paid during the year for interest                                                      |   |  $              4,496 |   |  $            3,371 |
|       Cash paid during the year for taxes                                                         |   |  $                     - |   |  $                   - |
|                                                                                                                       |   |   |   |   |
|       Non-cash investing and financing activities:                                                |   |   |   |   |
|                                                                                                                       |   |   |   |   |
|       Common stock issued for conversion of                                                       |   |   |   |   |
|           accrued salary                                                      |   |  $                     - |   |  $     1,739,000 |
|                                                                                                                       |   |   |   |   |
| The accompanying notes are an integral part of the unaudited condensed consolidated financial statements    |

----

----

----

----

|                                               Warrants  |      400,000  |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------|
|              Stock options                                                                                                                                                                                              | 12,800,000                             |
|                                                                                                                                                                                                                                                                                          | 13,200,000                             |

----

----

|                                                                                                                                                                          |          | As of                                                    | As of                                                                                   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------|----------------------------------------------------------|-----------------------------------------------------------------------------------------|
|                                                                                                                                                                          |          | June 30,2012 (Unaudited)                                 | December 31,2011                                                                        |
| Notes payable to finance companies, due in monthly installments of $3,695, including principal and interest at prime plus .25%  collateralized by certain equipment |   $ |   14,522                                       |   $     32,107                                       |
|                                                                                                                                                                          |          |                                                     |                                                                                    |
| Less current portion                                                                                                                                                          |          | 14,522                                                   |        32,107                                        |
|  Long term debt                                                                                                                                                          |  $       |           0 |  $              0 |

----

|                       | NumberOutstanding | Range of Exercise Price | NumberExercisable                                                         |
|----------------------------|-------------------|-------------------------|---------------------------------------------------------------------------|
|                       |              |                    |                                                                      |
| Balance, December 31, 2011 | 400,000           | $0.60                   | 400,000            |
| Issued                     | -                 | -                       | -                                                                         |
| Expired                    | -                 | -                       | -                                                                         |
| Forfeited                  | -                 | -                       | -                                                                         |
| Balance, June 30, 2012     | 400,000           | $0.60                   | 400,000                                                                   |

----

|                       | NumberOutstanding | Range of Exercise Price | NumberExercisable |
|----------------------------|-------------------|-------------------------|-------------------|
|                       |              |                    |              |
| Balance, December 31, 2011 | 12,850,000        | -                       | 12,850,000        |
| Issued                     | 950,000           | $0.20                   | 950,000           |
| Expired                    | (1,000,000)       | $(0.40)                 | (1,000,000)       |
| Forfeited                  | -                 | -                       | -                 |
| Balance, June 30, 2012     | 12,800,000        | $0.17                   | 12,800,000        |

----

| ExercisePrice | Number Outstanding at June 30, 2012 | Weighted Average Remaining Contractual Life | Weighted Average Exercise Price | Number Exercisable at June 30, 2012 | Weighted Average Exercise Price |
|---------------|-------------------------------------|---------------------------------------------|---------------------------------|-------------------------------------|---------------------------------|
| 0.15          | 5,800,000                           | 6.63                                        | 0.15                            | 5,800,000                           | 0.15                            |
| 0.18          | 6,050,000                           | 4.73                                        | 0.18                            | 6,050,000                           | 0.18                            |
| 0.20          | 950,000                             | 4.78                                        | 0.20                            | 950,000                             | 0.20                            |
| Total         | 12,800,000                          | -                                           | -                               | 12,800,000                          | -                               |

----

| Item 2.   | Management's Discussion and Analysis of Financial Condition and Results of Operations |
|---------------------|---------------------------------------------------------------------------------------|

----

----

----

----

| Item 3.   | Quantitative and Qualitative Disclosures About Market Risk |
|---------------------|------------------------------------------------------------|

| Item 4.   | Controls and Procedures |
|---------------------|-------------------------|

----

----

| Item 1.   | Legal Proceedings |
|---------------------|-------------------|

| Item 1A.   | Risk Factors |
|----------------------|--------------|

| Item 2.   | Unregistered Sales of Equity Securities and Use of Proceeds |
|---------------------|-------------------------------------------------------------|

| Item 3.   | Defaults Upon Senior Securities |
|---------------------|---------------------------------|

| Item 4.   | Mine Safety Disclosure |
|---------------------|------------------------|

| Item 5.   | OtherInformation |
|---------------------|------------------|

| Item 6.   | Exhibits |
|---------------------|----------|

| 31.1   | Form 302 Certification of Chief Executive Officer                                  |
|------------------|-----------------------------------------------------------------------------------------|
| 31.2        | Form 302 Certification of Principal Financial Officer                              |
| 32.1        | Form 906 Certification of Chief Executive Officer and Principal Financial Officer  |
| 101.INS          | XBRL Instance Document*                                                                 |
| 101.SCH          | XBRL Taxonomy Extension Schema Document*                                                |
| 101.CAL          | XBRL Taxonomy Extension Calculation Linkbase Document*                                  |
| 101.DEF          | XBRL Taxonomy Extension Definition Linkbase Document*                                   |
| 101.LAB          | XBRL Taxonomy Extension Label Linkbase Document*                                        |
| 101.PRE          | XBRL Taxonomy Extension Presentation Linkbase Document*                                 |

----

----